| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addictive personalities
|
Ranscombe, Peter
|
|
2014
|
13 |
6 |
p. 543-
1 p.
|
artikel
|
| 2 |
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
|
Dubois, Bruno
|
|
2014
|
13 |
6 |
p. 614-629
16 p.
|
artikel
|
| 3 |
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study
|
Sabater, Lidia
|
|
2014
|
13 |
6 |
p. 575-586
12 p.
|
artikel
|
| 4 |
A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease
|
Brayne, Carol
|
|
2014
|
13 |
6 |
p. 532-534
3 p.
|
artikel
|
| 5 |
Bruno Dubois: transforming the diagnosis of Alzheimer's disease
|
Holmes, David
|
|
2014
|
13 |
6 |
p. 541-
1 p.
|
artikel
|
| 6 |
Consumer choices in Parkinson's disease
|
The Lancet Neurology,
|
|
2014
|
13 |
6 |
p. 525-
1 p.
|
artikel
|
| 7 |
Corrections
|
|
|
2014
|
13 |
6 |
p. 536-
1 p.
|
artikel
|
| 8 |
Corrections
|
|
|
2014
|
13 |
6 |
p. 536-
1 p.
|
artikel
|
| 9 |
Corrections
|
|
|
2014
|
13 |
6 |
p. 536-
1 p.
|
artikel
|
| 10 |
Defining narcolepsy
|
Goodrick, Steven
|
|
2014
|
13 |
6 |
p. 542-
1 p.
|
artikel
|
| 11 |
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?
|
Charidimou, Andreas
|
|
2014
|
13 |
6 |
p. 538-540
3 p.
|
artikel
|
| 12 |
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? – Authors' reply
|
Greenberg, Steven M
|
|
2014
|
13 |
6 |
p. 540-
1 p.
|
artikel
|
| 13 |
Effects of fingolimod in relapsing-remitting multiple sclerosis
|
Sorensen, Per Soelberg
|
|
2014
|
13 |
6 |
p. 526-527
2 p.
|
artikel
|
| 14 |
Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial
|
Sturkenboom, Ingrid H W M
|
|
2014
|
13 |
6 |
p. 557-566
10 p.
|
artikel
|
| 15 |
Endovascular treatment for stroke: when does the window for good outcome close?
|
Albers, Gregory W
|
|
2014
|
13 |
6 |
p. 529-531
3 p.
|
artikel
|
| 16 |
Long-term cerebral consequences of sepsis
|
Widmann, Catherine N
|
|
2014
|
13 |
6 |
p. 630-636
7 p.
|
artikel
|
| 17 |
Michael Thomas Heneka
|
|
|
2014
|
13 |
6 |
p. 542-
1 p.
|
artikel
|
| 18 |
Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination
|
Partinen, Markku
|
|
2014
|
13 |
6 |
p. 600-613
14 p.
|
artikel
|
| 19 |
Neuropathological processes in sepsis
|
Sharshar, Tarek
|
|
2014
|
13 |
6 |
p. 534-536
3 p.
|
artikel
|
| 20 |
News in brief
|
|
|
2014
|
13 |
6 |
p. 544-
1 p.
|
artikel
|
| 21 |
Occupational therapy for Parkinson's disease: increasing awareness
|
Saint-Hilaire, Marie
|
|
2014
|
13 |
6 |
p. 527-529
3 p.
|
artikel
|
| 22 |
Painful and painless channelopathies
|
Bennett, David L H
|
|
2014
|
13 |
6 |
p. 587-599
13 p.
|
artikel
|
| 23 |
Paralysis lost: a new cause for a common parasomnia?
|
Rye, David
|
|
2014
|
13 |
6 |
p. 531-532
2 p.
|
artikel
|
| 24 |
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
|
Calabresi, Peter A
|
|
2014
|
13 |
6 |
p. 545-556
12 p.
|
artikel
|
| 25 |
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial
|
Khatri, Pooja
|
|
2014
|
13 |
6 |
p. 567-574
8 p.
|
artikel
|
| 26 |
Unruptured intracranial aneurysms: why we must not perpetuate the impasse for another 25 years
|
Naggara, Olivier
|
|
2014
|
13 |
6 |
p. 537-538
2 p.
|
artikel
|
| 27 |
Unruptured intracranial aneurysms: why we must not perpetuate the impasse for another 25 years – Authors' reply
|
Greving, Jacoba P
|
|
2014
|
13 |
6 |
p. 538-
1 p.
|
artikel
|
Tijdschrift beschrijving